How should a patient with epiretinal membrane and vitreous hemorrhage be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Epiretinal Membrane with Vitreous Hemorrhage

Refer this patient urgently to a vitreoretinal surgeon for evaluation and likely pars plana vitrectomy (PPV) with membrane peeling, as the combination of ERM and vitreous hemorrhage typically requires surgical intervention to restore vision and address both pathologies simultaneously. 1

Initial Assessment and Diagnostic Workup

The presence of both ERM and vitreous hemorrhage creates a complex clinical scenario requiring immediate specialist evaluation. Key diagnostic steps include:

  • Spectral-domain OCT (SD-OCT) when view permits - this is the gold standard for characterizing ERM, detecting vitreomacular traction, and assessing macular architecture 1
  • B-scan ultrasonography when fundus visualization is obscured by hemorrhage to rule out retinal detachment, which occurs in approximately 1% of cases and would alter surgical planning 1
  • Determine the source of vitreous hemorrhage - this is critical as it may indicate proliferative retinopathy, retinal tears, or vascular disease that requires concurrent treatment 2

Surgical Intervention: The Definitive Treatment

Vitrectomy is the treatment of choice for this combined pathology, as it addresses both conditions simultaneously and prevents complications from delayed treatment. The evidence strongly supports surgical intervention:

  • Approximately 80% of patients improve by at least 2 lines of visual acuity following vitrectomy for ERM 1
  • Combined vitrectomy allows clearance of hemorrhage, removal of ERM, and treatment of any underlying retinal pathology in a single procedure 2
  • Delaying surgery risks development of tractional retinal detachment, proliferative vitreoretinopathy, or permanent macular damage 3

Surgical Technique Considerations

The procedure should include:

  • Pars plana vitrectomy with complete removal of vitreous hemorrhage
  • ERM peeling to relieve tractional forces on the macula 1
  • Internal limiting membrane (ILM) peeling - however, this requires careful consideration:
    • Avoid ILM peeling if macular ischemia is present, as recent evidence shows significantly worse visual outcomes in ischemic cases 4
    • In non-ischemic cases, ILM peeling reduces ERM recurrence but may increase postoperative complications 4
  • Endolaser photocoagulation if proliferative retinopathy or retinal breaks are identified 2
  • Gas or silicone oil tamponade may be necessary if retinal detachment or breaks are present 2

Critical Surgical Pitfalls to Avoid

  • Iatrogenic retinal tears occur in approximately 11.8% of cases during membrane peeling - meticulous technique is essential 2
  • Macular hole formation can occur as a complication of vitrectomy for ERM, particularly during posterior vitreous detachment induction 1, 5
  • Endophthalmitis risk is less than 0.05% but requires strict sterile technique 1

Postoperative Management Protocol

Follow a structured postoperative schedule 1:

  • Postoperative day 1: Check for elevated/low IOP, wound integrity, and early complications
  • 1-2 weeks post-op: Assess for retinal detachment, wound leak, or infection
  • Monitor for cataract development - the majority of phakic patients develop progressive nuclear cataracts following vitrectomy 1
  • Counsel on retinal detachment symptoms: increased floaters, visual field loss, flashing lights 1
  • Gas precautions if tamponade used: no air travel, specific positioning requirements 1

Expected Outcomes and Prognosis

Based on the guideline evidence:

  • 73% of patients achieve better vision than preoperative baseline 1
  • Mean visual improvement from approximately 20/120 preoperatively to 20/40 postoperatively 1
  • Metamorphopsia improves in 83% of cases 1
  • Vitreous hemorrhage recurrence occurs in approximately 24% of cases, particularly if underlying proliferative retinopathy is not adequately treated 2

Special Considerations

If the patient has diabetic retinopathy or retinal vein occlusion as the hemorrhage source, assess for macular ischemia before surgery, as this significantly impacts the decision regarding ILM peeling 4. The presence of ischemia within the vascular arcades is a contraindication to ILM peeling due to substantially worse visual outcomes 4.

Timing of surgery: While some vitreous hemorrhages clear spontaneously, the presence of ERM makes observation less favorable. The combination typically warrants earlier surgical intervention rather than prolonged observation, as the ERM will not resolve spontaneously and may worsen macular architecture during the waiting period 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.